Do you want to receive the latest myeloma news and research for free, directly in your email inbox? You can with the Myeloma Minute!

Subscribe below to receive weekly email newsletters with up-to-the 'minute' information about multiple myeloma. The Myeloma Minute includes:

  • blogs and videos from Dr. Brian G.M. Durie,
  • inspirational videos,
  • information about drug recalls,
  • research announcements,
  • patient support events,
  • regional educational outreach,
  • advocacy action, and more.
Stay in Touch for the Latest Information
For late breaking news and events, subscribe to the Myeloma Minute!
The June 14, 2018 issue features more than 100 of the world’s myeloma experts debating on how to treat myeloma patients for 2018 and beyond. Also, Dr. Paul Richardson discusses clinical trials presented at ASCO 2018.
The June 7, 2018, issue covers the 2018 IMWG conference series, Dr. S. Vincent Rajkumar on ASCO, Laughs for Life, and more.
The May 31, 2018 issue covers the 9th Annual International Myeloma Working Group (IMWG) Summit from June 11 - 13 in Stockholm, Sweden, a Comedy benefit in New York, Brian D. Novis Grant Award applications, and more.
The May 24, 2018 issue covers the International Myeloma Working Group (IMWG) honoring researchers Prof. Philippe Moreau, MD, and Dr. Sigurdur Kristinsson, European patient meetings, and more.
The May 17, 2018 issue covers abstracts for the studies to be presented at the upcoming 2018 American Society of Clinical Oncology (ASCO) annual meeting. Also discussed is an IMF study conducted in partnership with AbbVie examining the role of genetic mutation in outcomes of myeloma patients.
In the May 5, 2018 issue, Dr. Brian G.M. Durie, IMF Chairman of the Board, comments about the prevalence of multiple myeloma in the Asia-Pacific region. Also covered is the FDA approval of a fifth indication for Darzelex (daratumuab).

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.